mRNA |
ML203 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.004 |
mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
0.081 |
0.004 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.005 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.091 |
0.005 |
mRNA |
Sorafenib |
FIMM |
pan-cancer |
AAC |
-0.43 |
0.007 |
mRNA |
SRT-1720 |
CTRPv2 |
pan-cancer |
AAC |
0.097 |
0.009 |
mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
0.093 |
0.01 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.075 |
0.01 |
mRNA |
niclosamide |
CTRPv2 |
pan-cancer |
AAC |
-0.091 |
0.01 |
mRNA |
ruxolitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.087 |
0.01 |